EMJ GOLD - European Medical Journal

Continue

Pharma News, Views & Analysis

Filter Advertise With Us
Illustration of a horizontal vaccine

Roche's twice-yearly MS injection wins FDA approval

The FDA has approved Roche’s subcutaneous injection for relapsing multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS).

Company reputation key to HCP prescribing decisions

New research shows that healthcare professionals consider a company’s leadership in a specific disease area and its overall reputation to be influential in prescribing decisions.

FDA lifts partial clinical hold on Rezolute hyperinsulinism treatment

The lift is based on new research showing that the previous adverse effects in laboratory rats may not have been caused by the drug itself.

New AI-focused RNA collaboration for Eli Lilly

Eli Lilly has entered into a research collaboration with Genetic Leap, a private company focused on AI, to advance the development of RNA-based genetic medicines.  

NICE endorses Novartis’ take home drug for rare blood disorder

NICE recommends an oral therapy for adults with PNH, marking the 1000th medicine evaluated since its inception in 1999.

Sanofi's MS drug delivers surprising Phase III results

It’s been both a good and bad week for French pharmaceutical company Sanofi, as their MS drug candidate, received mixed trial results.

Second mpox vaccine wins FDA approval

The FDA has formally approved Emergent BioSolutions’ smallpox and mpox vaccine for use in preventing the virus in people at high risk of infection. 

Novartis and Lindy Biosciences enter drug delivery partnership

The deal centres on Lindy’s microglassification technology, which facilitates high-concentration subcutaneous injections of biologic drugs.